KLJ — Nad Reduction (U.V.), Phosphohexose Isomerase Class I

FDA Device Classification

FDA product code KLJ covers "Nad Reduction (U.V.), Phosphohexose Isomerase", a Class I medical device regulated under 21 CFR 862.1570. Submissions are reviewed by the Clinical Chemistry panel. At least 1 recent 510(k) clearance has been granted under this product code.

Classification Details

Product Code
KLJ
Device Class
Class I
Regulation Number
862.1570
Submission Type
Review Panel
CH
Medical Specialty
Clinical Chemistry
Implant
No

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K770577sigma chemicalDETER. OF PHOSPHOHEXOSE ISOMERASEJune 17, 1977